BioSpace News Archive

COMPASS Pathways plc announced today that management will participate in three upcoming events as follows: Cowen 43rd Annual Health Care Conference.

ViaLase, Inc. today announced positive results of the first-in-human study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) performed with the ViaLase technology.

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”) announced today that members of its management team are scheduled to participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference in Orlando, Florida, on March 7, 2023.

American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (the “Company” or “Aires”) announces that further to the review by the Ontario Securities Commission (“OSC”) of the Company’s continuous disclosure, and a subsequent request from OSC staff in connection therewith, the Company has made corrective disclosure with respect to the following documents:

Akadeum Life Sciences Inc., a global leader in buoyancy-based cell separation technology, announces it has been named in Fast Company’s 10 Most Innovative Biotech Companies of 2023 as part of the prestigious annual list of the World’s Most Innovative Companies.

Prana Thoracic, Inc. has announced the closing of a $3 million founding Series A financing led by New World Angels.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months and full-year ended December 31, 2022 and provided an update on key corporate milestones.

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that it will report fourth quarter 2022 financial results on Tuesday, March 14, 2023 before the market opens.

CorMedix Inc. announced updates related to the FDA compliance remediation activities at its primary contract manufacturing organization and heparin active pharmaceutical ingredient supplier, as well as updated timelines for potential resubmission of its New Drug Application under various scenarios.

PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”) today announced that members of management will present at the upcoming Virtual Key Bank Life Sciences & MedTech Investor Forum. Management is scheduled to present on Tuesday, March 21 at 12:45 p.m. Eastern Time.